SUMMARY The clinical usefulness of the Arden grating test in assessing early abnormalities in retinal function of diabetics has been explored. Although the test revealed significant differences in constrast sensitivities between diabetics and normal persons, the large variances in the test scores of diabetics limit its use as a clinical tool for the screening of diabetic patients.
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Diabetes is said to be associated with detectable alterations in colour perception before the development of ophthalmoscopically detectable retinopathy.' The Arden grating test2 is claimed to detect disturbances of retinal integrative function even when acuity is normal. The test was used to assess whether it was of clinical value in detecting early abnormality in retinal function in diabetic subjects without retinopathy or in those with established retinopathy and whether it was useful in differentiating serious from not serious retinopathy.
Materials and methods
The test was carried out as described by Arden and Jacobson2 except that standard artificial daylight was used (Verivide Cabinet, Leslie Hubble Ltd patients with proliferative retinopathy ranged from 6/5 to 6/36 with a mean level of 6/9 and a median of 6/9. For analysis only one eye (the right) was used from each patient tested. 7 from patients with either background retinopathy or Plate number proliferative retinopathy (Fig. 4) , as did the same Fig. 2 Thus the results for patients with diabetes but without retinopathy were significantly different in plates 3, 4, and 5 from those with background retinopathy and in all plates except plate 2 when compared with results from patients with proliferative retinopathy. Even when background retinopathy was compared with proliferative retinopathy, this latter group showed significantly increased thresholds for plates 5, 6, and 7 as compared with the former group. The results of the above comparisons are summarised in Fig. 5 . The comparisons were made by a modified t test, applicable to cases with unequal variances.
It is worth noting that unlike the control group, in which the variance for each plate was similar (SD= 1P89 to 2-56), in all the diabetic groups the variances tended to be greater than in the controls, and particularly when higher frequency plates were used.
An F test was used to assess whether the increased variance was significant, and significant values are marked with an asterisk in subjects show a lower threshold for plates 5 and 6 (1-6 cycles/degree and 3-2 cycles/degree respectively) than those previously published by Arden and Jacobson2 but are in agreement with figures recently published by Singh et al. 3 The results of the Arden grating test are to some degree age-related,4 and the difference may reflect a different age composition in Arden and Jacobson's material and our own. It is of interest that diabetic patients without retinopathy show increased thresholds at the higher spatial frequencies tested, which suggests that the functional deficit for these frequencies may precede ophthalmoscopically visible retinopathy.
Even within the group of diabetic patients increasing severity of retinopathy (background versus proliferative) was, as might be expected, associated with a decreased contrast sensitivity to grating patterns and an increasing variability in results, especially for plates of high frequency content.
Unfortunately the relatively large standard deviations in the groups affected by retinopathy resulted in considerable overlap between groups, so that the test was not found to be clinically useful in separating individual diabetic patients into serious or not serious 
